fa استفاده از بیوگلاس ها در درمان تومورهای خوش خیم استخوان و شکستگی های جوش نخورده پس از عمل جراحی در سال 81ـ1380 در بیمارستان امام خمینی اهواز مقاله پژوهشی Original Research Article <div style="text-align: justify;"><strong><span style="font-size:18px;"><span style="font-family:Times New Roman;"><span style="color:#ffffff;"><span style="background-color:#16a085;">Introduction:</span></span></span></span></strong><span style="font-size:16px;"><span style="font-family:Times New Roman;"> Bone grafting has been recommended in various clinical problems such as nonunion fractures after surgery, fixation of fractures, filling remaining cavities in bones after debridement and curtage in osteomyelitis and tumors. The use of Bioglass material are recommended by manufacturers when bone grafting is not possible. In this investigation, the use of Nova bone (Bioglass) was studied on the treatment of benign tumors and nonunion fractures after surgery. </span></span><br> <strong><span style="font-size:18px;"><span style="font-family:Times New Roman;"><span style="color:#ffffff;"><span style="background-color:#16a085;">Materials and Methods:</span></span></span></span></strong><span style="font-size:16px;"><span style="font-family:Times New Roman;"> In this case series study 14 patients with bone tumors and 2 patients with nonunion fracture were studied over one year period. All bone tumors were benign and consisted of 3 cases of nonossifying fibroma (N.O.F), 3 cases of anurismal bone cyst (A.B.C.), 2 cases of unicameral bone cyst (U.B.C), one case of ossifying fibroma and 5 cases of giant call tumors (G.C.T). </span></span><br> <span style="font-size:18px;"><span style="font-family:Times New Roman;"><strong><span style="color:#ffffff;"><span style="background-color:#16a085;">Results:</span></span></strong></span></span><span style="font-size:16px;"><span style="font-family:Times New Roman;"> Unpredictable clinical complications were not seen in any of the cases. The average recovery time for benign tumors after nova bone grafting was 3 months and for nonunion fractures was 6 months. Recurrence were occurred in all cases of giant cell tumors.</span></span><br> <span style="font-size:18px;"><span style="font-family:Times New Roman;"><strong><span style="color:#ffffff;"><span style="background-color:#16a085;">Conclusion: </span></span></strong></span></span><span style="font-size:16px;"><span style="font-family:Times New Roman;">Nova bone is appropriate for use in benign tumors of bone, but we do not recommend it in the treatment of patients with malignant or sometimes malignant tumors of bone such as giant cell tumors.</span></span></div> BONE GRAFTING, BONE TUMOR, BIOGLASS, NONUNION FRACTURE 31 37 http://journal.zums.ac.ir/browse.php?a_code=A-10-1-23&slc_lang=fa&sid=1 Seyed Ali Marashinezhad سیدعلی مرعشی نژاد 5200319475328460070053 5200319475328460070053 Yes Seyed Alireza Bassampour سیدعلیرضا بصام پور 5200319475328460070054 5200319475328460070054 No